Multiple sclerosis (MS) is a chronic condition that affects the central nervous system. MS is considered to be an immune-mediated disease, which is a disease that causes the body’s immune system to ...
Multiple sclerosis (MS) and Lyme disease are diseases that stem from very different causes. MS is a life-long autoimmune condition that disrupts the communication between your brain and your body.
Experts in MS discuss the challenges related to treatment selection and management when MS disease progression occurs. Neil Minkoff, MD: There’s a group of patients that, no matter what we start, will ...
Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...
Monoclonal antibody DMTs, especially anti-CD20 therapies, effectively prevent relapses but have limited impact on progressive MS. Progressive MS involves compartmentalized CNS inflammation, with ...
For the first time ever, researchers have identified a genetic variant that may help predict faster symptom progression — and thus, more rapid declines in mobility and independence — in people with ...
Hello! I cover the Northtowns for 7 News WKBW. If you have a story idea, please email me at [email protected] BUFFALO, NY (WKBW) — There is a first-of-its-kind medical study happening at the ...
A virus that infects more than 90% of adults and causes the “kissing disease” has been linked with the onset of multiple sclerosis in a new study. Researchers at Harvard University have added further ...
Infectious mononucleosis – also known as "mono" or "the kissing disease" – in childhood or adolescence is associated with an increased risk of developing multiple sclerosis (MS) as an adult, according ...
COPENHAGEN, Denmark — A higher cumulative genetic burden for depression is associated with an increased risk for relapse and worsening disability in people with multiple sclerosis (MS), early results ...
Despite COVID-19 triggering autoimmune conditions in healthy individuals, it does not appear to increase the risk for clinical and MRI disease activity or motor and cognitive worsening in people with ...